Device Trial Radar · NCT04508335
Feasibility Study of the Reia Vaginal Pessary
Last checked: Nov 20, 2026Latest source record: Nov 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
78
Actual
Start
Nov 21, 2021
Primary completion
Jun 16, 2023
Study completion Jun 16, 2023
Sponsor
- Lead sponsor
- Reia, LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 11, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to obtain preliminary data on the effectiveness, safety, function, comfort, and patient satisfaction with a novel vaginal pessary design for the use in women who suffer from symptoms of pelvic organ prolapse (POP) and have already opted for non-surgical management. Recruited patients will have Stage II POP or greater and will be current users of a Gellhorn or ring style pessary. Following enrollment, each subject will enter a 1-month wash out period in which they will continue using their current pessary so that baseline subjective and objective data can be collected. They will then be fit with a study pessary and enter a 3-month treatment phase. Comparative, subjective, and objective data will be collected at the conclusion of the study.
Conditions
- Pelvic Organ Prolapse
Interventions
Reia Vaginal PessaryDevice
Reia Vaginal Pessary
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pelvic Floor Distress Inventory-20 (PFDI-20)Time frame: At enrollment [Week 0] and post treatment [Week 16]
- Adverse EventsTime frame: Throughout study, an average of 16 weeks - AEs may be reported at any time
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Boston Urogynecology Associates
Cambridge, Massachusetts
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.